An Update on Inflammation in Atherosclerosis: How to Effectively Treat Residual Risk

202320 citationsReviewhybrid Open Access

Authors

Niekbachsh Mohammadnia · Radboud University Medical Center

Saloua El Messaoudi · Radboud University Medical Center

Jan H. Cornel · Radboud University Nijmegen

Abstract

Based on current evidence and ongoing clinical trials, targeting inflammation alongside optimal lipid lowering is likely to be central to the future treatment of ASCVD. (Clin Ther. 2023;45:XXX-XXX) © 2023 Elsevier HS Journals, Inc.

Topics & Keywords

Inflammasome and immune disorders Immune responses and vaccinations Biomarkers in Disease Mechanisms

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Clinical Therapeutics

Volume 45, Issue 11, pp. 1055-1059

DOI: 10.1016/j.clinthera.2023.08.016

Field-Weighted Citation Impact: 3.11